BIOMAT Database Logo BIOMAT Database Logo

Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide. 1965

E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary

Related Publications

E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.
October 1964, The Journal of clinical endocrinology and metabolism,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
August 1970, Diabetologia,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Serum immunoreactive insulin response to oral glucose and intravenous sodium tolbutamide administration in relation to obesity.
June 1972, Israel journal of medical sciences,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Plasma insulin response to an oral glucose load in noncoronary heart disease.
February 1971, Chest,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Blood glucose, plasma insulin and coronary heart disease.
January 1973, Advances in cardiology,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Plasma insulin response to oral glucose load in Menière's disease.
January 1988, American journal of otolaryngology,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Plasma insulin response to oral glucose load in Menière's disease.
January 1986, American journal of otolaryngology,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose.
May 1983, Diabetes,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Plasma insulin response following oral and intravenous glucose in pregnant diabetic women.
September 1976, Obstetrics and gynecology,
E A Nikkilä, and T A Miettinen, and M R Vesenne, and R Pelkonen
Insulin response to oral glucose loading and coronary artery disease in nondiabetics.
September 2005, International heart journal,
Copied contents to your clipboard!